Kalvista Pharmaceuticals, Inc. (KALV)

Last Three Months

22-Aug-24 -- 21-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drugs - Generic

Drugs

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

15

0

3

+1

0

+2

0

+3

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
19-Nov-24 7:18 PM View:	18-Nov-24 Option Sale ($66.57K)	Yea Christopher Chief Development Officer		Kalvista Pharmaceuticals, Inc. - KALV	7% 84.47K to 89.98K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 7:18 PM View:	18-Nov-24 Option Sale ($74.77K)	Audhya Paul K. Chief Medical Officer		Kalvista Pharmaceuticals, Inc. - KALV	16% 80.88K to 94.2K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 7:19 PM View:	18-Nov-24 Option Sale ($133.29K)	Palleiko Ben CHIEF EXECUTIVE OFFICER Director		Kalvista Pharmaceuticals, Inc. - KALV	10% 242.53K to 266.6K	0	0	--	--	Show Txns Hide Txns